Lonza(LZAGY) - 2018 Q4 - Earnings Call Presentation

Corporate Lonza Achieved Another Excellent Full-Year Result in 2018 with 9% Organic Sales Growth and Strong Profitability Driven by Healthcare Businesses Richard Ridinger – CEO Marc Funk – COO Pharma & Biotech Rodolfo Savitzky – CFO Corporate | FYR 2018 | 30 January 2019 Table of Contents | --- | --- | --- | |----------------------------------------------------------------|-------|-------| | | | | | FYR 2018 Corporate Overview | | | | | | | | FYR 2018 Financial Summary | | | | FYR 2018 Lonza Segments | | | ...